Relevant bibliographies by topics / Malignancy tumor

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Malignancy tumor'

Author: Grafiati
Published: 28 May 2022
Last updated: 30 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Malignancy tumor.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Malignancy tumor"

1

Yarovoy, A. A., A. V. Kotelnikova, A. G. Galbatsova, and A. D. Matyaeva. "Retinocytoma malignancy." Russian ophthalmology of children, no. 3 (October 10, 2023): 27–32. http://dx.doi.org/10.25276/2307-6658-2023-3-27-32.

Full text
Abstract:
In this article we described a clinical case where benign tumor retinocytoma were transformed into malignant tumor retinoblastoma. This work reflects the clinical picture and diagnostic methods necessary for making a clinical diagnosis. Considering the possibility of retinocytoma malignant transformation, patients should be under lifelong supervision. Key words: retinocytoma, retinoblastoma, protein p27, nonsense mutation, benign tumors in children, malignancy
APA, Harvard, Vancouver, ISO, and other styles
2

Hanson, Joshua Anspach, and Abiy B. Ambaye. "Adult Testicular Granulosa Cell Tumor: A Review of the Literature for Clinicopathologic Predictors of Malignancy." Archives of Pathology & Laboratory Medicine 135, no. 1 (2011): 143–46. http://dx.doi.org/10.5858/2009-0512-rsr.1.

Full text
Abstract:
Abstract Adult testicular granulosa cell tumors are rare sex cord–stromal tumors of which only 28 have been previously reported. As compared with their ovarian counterparts, these tumors may follow a more aggressive course because the proportion of malignant cases is higher. To date, there are no clinical or pathologic features that definitively predict malignancy. We reviewed all prior case reports for features that may predict their malignant potential. Tumor size greater than 5.0 cm is the only feature statistically associated with malignancy. Mitotic count, tumor necrosis, patient age, and
APA, Harvard, Vancouver, ISO, and other styles
3

Palmerini, Emanuela, Piero Picci, Peter Reichardt, and Gerald Downey. "Malignancy in Giant Cell Tumor of Bone: A Review of the Literature." Technology in Cancer Research & Treatment 18 (January 1, 2019): 153303381984000. http://dx.doi.org/10.1177/1533033819840000.

Full text
Abstract:
Background: Primary and recurrent giant cell tumor of bone is typically benign; however, rarely giant cell tumor of bone can undergo malignant transformation. Malignancy in giant cell tumor of bone may be primary (adjacent to benign giant cell tumor of bone at first diagnosis) or secondary (at the site of previously treated giant cell tumor of bone). Malignant giant cell tumor of bone has a poor prognosis; it is important to distinguish malignant from benign lesions to facilitate appropriate management. The true incidence of malignant giant cell tumor of bone is not known, probably owing to in
APA, Harvard, Vancouver, ISO, and other styles
4

Nanjappa, Santhosh, Saurabh Boralkar, Prasant Chandra, Samir Gupta, and Mangesh Londe. "Double Troubles – Managing a Series of Cases with Dual Primary Malignancies." Medical Journal of Dr. D.Y. Patil Vidyapeeth 18, no. 2 (2025): 312–19. https://doi.org/10.4103/mjdrdypu.mjdrdypu_531_24.

Full text
Abstract:
ABSTRACT The reported incidence of multiple primary malignant tumor (MPMT) is between 0.734% and 11.7%. Double primary malignancy is the occurence of second primary malignant tumor of another organ in patients with a known malignant tumor. We present four cases with dual primary malignancy and treatment of these dual malignancies. All patients who underwent surgical treatment for cancers between April 2020 and April 2024 were reviewed, and the patients who had dual primary malignant tumors were identified. Hereby, we share our experience regarding multiple primary malignant tumors, their initi
APA, Harvard, Vancouver, ISO, and other styles
5

Pinello, Katia, Irina Amorim, Isabel Pires, et al. "Vet-OncoNet: Malignancy Analysis of Neoplasms in Dogs and Cats." Veterinary Sciences 9, no. 10 (2022): 535. http://dx.doi.org/10.3390/vetsci9100535.

Full text
Abstract:
Analysis of canine and feline tumor malignancy data can help clinicians identify high-risk patients and make more accurate decisions. Based on a sample of 16,272 cancer records, including 3266 cats and 13,006 dogs, collected from January 2019 to December 2021 in the Vet-OncoNet Network database, this study aimed to compare the tumor malignancy profile between cats and dogs, considering animal-related factors (sex, age, and breed), topography, and geographic location using a mixed-effects logistic regression model. Cats had a higher proportion of malignant tumors (78.7%) than dogs (46.2%), and
APA, Harvard, Vancouver, ISO, and other styles
6

Kudziev, A. V., A. S. Nazarov, Yu V. Belyakov, et al. "Surgical treatment of malignant triton tumor of the spinal root (a rare clinical observation)." Russian Neurosurgical Journal named after Professor A. L. Polenov 15, no. 2 (2023): 140–44. https://doi.org/10.56618/2071-2693_2023_15_2_140.

Full text
Abstract:
Malignant newt tumor (MNT) is a highly aggressive malignant neoplasm classified as a variant of malignant peripheral nerve sheath tumor (MPNT) with rhabdomyoblast differentiation. MDRF with divergent (heterologous) differentiation with the presence of a rhabdoid component is extremely rare, accounting for 5 % of all MRRF, which accounts for approximately 2 % of all soft tissue sarcomas. A subgroup of tumors in which malignant Schwann cells coexist with malignant rhabdomyoblasts is called malignant newt tumor (MNT) [10]. In most published clinical observations, newt tumor malignancy occurs in t
APA, Harvard, Vancouver, ISO, and other styles
7

Black, Keith L., Randall A. Hawkins, Kenneth T. Kim, Donald P. Becker, Carole Lerner, and Donna Marciano. "Use of thallium-201 SPECT to quantitate malignancy grade of gliomas." Journal of Neurosurgery 71, no. 3 (1989): 342–46. http://dx.doi.org/10.3171/jns.1989.71.3.0342.

Full text
Abstract:
✓ A quantitative preoperative technique using thallium-201 single-photon emission computerized tomography is described which predicts whether specific gliomas are of high- or low-grade malignancy. An index, based on the ratio of thallium uptake in the tumor versus the homologous contralateral brain, was calculated and compared with tumor histology. The index in 14 patients with low-grade malignant gliomas was 1.27 ± 0.40 in contrast to an index of 2.40 ± 0.61 in 11 patients with high-grade malignant gliomas (p < 0.0005). Whether gliomas were of low- or high-grade malignancy could be predict
APA, Harvard, Vancouver, ISO, and other styles
8

Kim, Eun Pyo, Giup Jang, Jin-Wook Kim, et al. "MicroRNA and Messenger RNA Expression Profiles in Canine Mammary Gland Tumor." International Journal of Molecular Sciences 24, no. 3 (2023): 2618. http://dx.doi.org/10.3390/ijms24032618.

Full text
Abstract:
Canine mammary gland tumor (CMT) is the most frequently diagnosed neoplasm in intact female dogs. As prognosis depends on the malignancy of tumors and metastasis levels, early and accurate diagnosis are crucial for prolongation of life expectancy. The genetic similarity of dogs with humans in addition to environmental and physiological similarities make them ideal models for the study of cancer. In this study, we analyzed differentially expressed microRNAs followed by RNA-Seq to investigate the alterations in mRNA levels based on the malignancy (benign, malignant) and the biopsy locations (tum
APA, Harvard, Vancouver, ISO, and other styles
9

Korgali, Esat, Gokce Dundar, Gokhan Gokce, et al. "Giant Malignant Pheochromocytoma with Palpable Rib Metastases." Case Reports in Urology 2014 (2014): 1–4. http://dx.doi.org/10.1155/2014/354687.

Full text
Abstract:
Pheochromocytoma is a rare and usually benign neuroendocrine neoplasm. Only 10% of all these tumors are malignant and there are no definitive histological or cytological criteria of malignancy. Single malignancy criteria are the presence of advanced locoregional disease or metastases. We report a case, with a giant retroperitoneal tumor having multiple metastases including palpable rib metastases, who was diagnosed as a malignant pheochromocytoma. The patient was treated with surgery. The literature was reviewed to evaluate tumor features and current diagnostic and therapeutic approaches for p
APA, Harvard, Vancouver, ISO, and other styles
10

Salaouatchi, Mohamed Tayeb, Sandra De Breucker, Héloise Rouvière, et al. "A Rare Case of a Metastatic Malignant Abrikossoff Tumor." Case Reports in Oncology 14, no. 3 (2021): 1868–75. http://dx.doi.org/10.1159/000520385.

Full text
Abstract:
Abrikossoff tumor, also called granular cell tumor (GCT), is a neoplasm of the soft tissues which is most commonly a solitary, painless, and benign tumor. However, 2% of Abrikossoff tumors can be malignant. We report here the case of a 75-year-old male who presented a local recurrence of Abrikossoff tumor of the left thigh. The anatomopathological analysis concluded to a malignant GCT, and the F-18 fluorodeoxyglucose positron emission tomography showed multiple lesions in the lymph nodes and bones. The potential conversion to malignancy should alert practitioners because of the extremely poor
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Malignancy tumor"

1

OKAMOTO, TOMOMITSU, SHIHO TANAKA, FUMITAKA KIKKAWA, et al. "Unexpected Ovarian Malignancy Found after Laparoscopic Surgery in Patients with Adnexal Masses : A Single Institutional Experience." Nagoya University School of Medicine, 2014. http://hdl.handle.net/2237/19486.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Norlén, Olov. "Small Intestinal Neuroendocrine Tumor : A Rare Malignancy with Favorable Outcome." Doctoral thesis, Uppsala universitet, Endokrinkirurgi, 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-185071.

Full text
Abstract:
Small intestinal neuroendocrine tumor (SI-NET) is the most common small bowel tumor in Europe and USA, with an annual incidence of around 0.3-1.3/100000 persons. SI-NETs are the most common type of gastroenteropancreatic NETs (GEP-NETs), and they are known for their ability to produce hormones such as tachykinins and serotonin, as well as for their favorable long-term prognosis in comparison to gastrointestinal adenocarcinoma. The overall aim of the thesis was to investigate unknown or unclear aspects of SI-NET disease, in connection with prognosis, treatment and follow-up. Paper I confirmed s
APA, Harvard, Vancouver, ISO, and other styles
3

Tachijian, Nataly. "The effect of deactivation or silencing of tumor stroma with angiogenesis inhibitor on malignancy of tumor metastases." Thesis, Uppsala universitet, Institutionen för farmaceutisk biovetenskap, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-445622.

Full text
Abstract:
Background: Neuroblastoma (NB) is a pediatric tumor in infants and young children. The survival rate is only around 50 percent for high-risk NB despite advanced and intense multi-modal therapy. Current research aims to find new effective treatment additional to modern therapy to improve prognosis of high-risk NB in children. As such, SU11248 may be a valuable approach for improving treatment and survival as growth factors have crucial roles in tumor growth, angiogenesis, and metastasis. Aim: The aim of this investigation was to examine tissues from SU11248 treated and nontreated tumor-bearing
APA, Harvard, Vancouver, ISO, and other styles
4

Рудна, М. М., Валентина Володимирівна Маркевич, Валентина Владимировна Маркевич та Valentyna Volodymyrivna Markevych. "Стан профілактики злоякісних пухлин жіночих статевих органів у сучасній гінекології". Thesis, Видавництво СумДУ, 2009. http://essuir.sumdu.edu.ua/handle/123456789/4686.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Duncan, Kaylia Mekelda. "Dynamics of tumor progression and therapy response in Il-6 and Myc driven plasma cell malignancy." Thesis, University of Iowa, 2013. https://ir.uiowa.edu/etd/4619.

Full text
Abstract:
Emerging evidence indicates that 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) and computed tomography (CT) are useful imaging modalities for evaluating tumor progression in transgenic mouse models of solid human cancers, but the potential of integrated FDG-PET/CT for assessing tumor development in genetically engineered mouse models of liquid human cancers - including neoplasms of immunoglobulin (Ig)-producing plasma cells - has not been established. Here we use a double-transgenic strain of laboratory mice, designated C.IL6Myc, that recapitulates key features of human plasma
APA, Harvard, Vancouver, ISO, and other styles
6

Shen, Daniel Hueng-Yuan. "Sodium iodide symporter based strategy for treatment of thyroid and non-thyroid malignancy." Connect to this title online, 2003. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1047493162.

Full text
Abstract:
Thesis (Ph. D.)--Ohio State University, 2003.<br>Title from first page of PDF file. Document formatted into pages; contains xiv, 133 p.; also includes graphics Includes bibliographical references (p. 116-133). Available online via OhioLINK's ETD Center
APA, Harvard, Vancouver, ISO, and other styles
7

Sharma, Purva, Bahaaeldin Youssef, Sakshi Singal, and Devapiran Jaishankar. "In Situ Follicular Neoplasia yet another Spectrum That Extends From Normalcy to Overt Malignancy." Digital Commons @ East Tennessee State University, 2020. https://dc.etsu.edu/asrf/2020/presentations/28.

Full text
Abstract:
In situ follicular neoplasia (ISFN) is defined as a monoclonal proliferation of B cells with immunophenotypic and genetic features of follicular lymphoma (FL) but confined to germinal centers of lymph nodes or other organs. It may not be associated with underlying overt lymphoma. It can be associated with lymphoproliferative disorders other than FL. A fifty-seven-year-old caucasian male initially presented with atypical chest pain, which led to cardiology evaluation. Patient underwent a coronary CT angiogram, which revealed a calcium score of 0, however also incidentally revealed mediastinal l
APA, Harvard, Vancouver, ISO, and other styles
8

Ververis, Megan, Ahmed Minhas, Elnora MD Spradling, and Laura MD Stewart. "A Case Report of Krukenberg Tumor Arising From Small Bowel Adenocarcinoma." Digital Commons @ East Tennessee State University, 2018. https://dc.etsu.edu/asrf/2018/schedule/67.

Full text
Abstract:
Case Report: Krukenberg tumor is a metastatic adenocarcinoma of the ovary that classically arises from the gastrointestinal tract, most often as a metastasis from the stomach as the primary origin, followed by colon. Krukenberg tumors are very rare malignant tumors of the ovary, only accounting for 1-2% of all ovarian malignancies. They tend to present with bilateral involvement. The most common presenting symptoms are abdominal pain, distention, and ascites, secondary to the large ovarian masses. Postmenopausal vaginal bleeding is a rare presenting symptom of a Krukenberg tumor. The diagnosis
APA, Harvard, Vancouver, ISO, and other styles
9

Roberts, Ryan David. "Taking Corrective Action: Efforts To Change The Malignancy-Promoting Behaviors Of Monocytes And Macrophages Elicited By Tumor Education." Columbus, Ohio : Ohio State University, 2008. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1210630643.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Li, Xuebing. "Chemical biology research on the UCHL1-HIF axis toward development of molecular targeted anticancer drugs." Doctoral thesis, Kyoto University, 2020. http://hdl.handle.net/2433/253236.

Full text
Abstract:
付記する学位プログラム名: 充実した健康長寿社会を築く総合医療開発リーダー育成プログラム<br>京都大学<br>0048<br>新制・課程博士<br>博士(薬科学)<br>甲第22400号<br>薬科博第122号<br>新制||薬科||13(附属図書館)<br>京都大学大学院薬学研究科医薬創成情報科学専攻<br>(主査)教授 掛谷 秀昭, 教授 二木 史朗, 教授 土居 雅夫<br>学位規則第4条第1項該当<br>Doctor of Pharmaceutical Sciences<br>Kyoto University<br>DFAM
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Malignancy tumor"

1

Clavien, Pierre-Alain, and Stefan Breitenstein, eds. Malignant Liver Tumors. Wiley-Blackwell, 2010. http://dx.doi.org/10.1002/9781444317053.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Moliterno Gunel, Jennifer, Joseph M. Piepmeier, and Joachim M. Baehring, eds. Malignant Brain Tumors. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-49864-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Rongioletti, Franco, Irina Margaritescu, and Bruce R. Smoller. Rare Malignant Skin Tumors. Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-2023-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Beck, Lutwin, Ekkehard Grundmann, Rolf Ackermann, and Hans-Dietrich Röher, eds. Hormone-Related Malignant Tumors. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-83816-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

1918-, Brooks Benjy Frances, and Robert E. Gross Symposium (6th : 1984 : M.D. Anderson Hospital and Tumor Institute), eds. Malignant tumors of childhood. University of Texas Press, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Thiagarajan, Balasubramanian. Malignant tumors of larynx. otolaryngology online, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lutwin, Becker, ed. Hormone-related malignant tumors. Springer-Verlag, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

W, Hancock Barry, ed. Malignant lymphoma. Arnold, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Jellinger, Kurt, ed. Therapy of Malignant Brain Tumors. Springer Vienna, 1986. http://dx.doi.org/10.1007/978-3-7091-8876-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Cobin, Rhoda H., and David King Sirota, eds. Malignant Tumors of the Thyroid. Springer New York, 1992. http://dx.doi.org/10.1007/978-1-4613-9127-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Malignancy tumor"

1

Ayag, Hatice, Sehmus Ertop, Muzeyyen Aslaner Ak, and Birsen Sahip Yesiralioglu. "Immunotherapy in Hematological Malignancy." In Immunotherapy in Human Cancers. Nobel Tip Kitabevleri, 2024. http://dx.doi.org/10.69860/nobel.9786053359388.4.

Full text
Abstract:
Tumor immune tolerance represents a significant obstacle to effective cancer therapy. A multitude of pathways through which tumors evade immune surveillance have been identified . These developments have prompted a reevaluation of the "hallmarks of cancer" and have spurred the development of numerous promising immunotherapies. Various categories of immunotherapies, including stem cell transplantation, immune checkpoint inhibitors, antigen-targeted antibodies, antibody-drug conjugates, tumor vaccines, and adoptive cell therapies, have been devised for treating hematologic cancers, with ongoing
APA, Harvard, Vancouver, ISO, and other styles
2

Nadel, Helen, Barry Shulkin, Zvi Bar-Sever, and Francesco Giammarile. "Pediatric Malignancies." In A Practical Guide for Pediatric Nuclear Medicine. Springer Berlin Heidelberg, 2023. http://dx.doi.org/10.1007/978-3-662-67631-8_12.

Full text
Abstract:
AbstractThe most common childhood malignancy is leukemia (30%), followed by brain tumors (20%), lymphomas, both Hodgkin’s (HL) and non-Hodgkin’s lymphoma (NHL) (14%), neuroblastoma (7%), soft tissue sarcoma (7%), Wilms’ tumor (6%), bone tumors (5%), germ cell tumors (3%), melanoma (3%), and hepatic tumors (1%). Their incidence varies according to patient age. Less common pediatric malignancies include head and neck cancer, Langerhans cell histiocytosis (LCH), germ cell tumors, neurofibromatosis type 1 with suspected malignant transformation, adrenocortical carcinoma, gastrointestinal stromal t
APA, Harvard, Vancouver, ISO, and other styles
3

Hoffman, Freddie A. "Metabolic Changes in Malignancy." In Influence of Tumor Development on the Host. Springer Netherlands, 1989. http://dx.doi.org/10.1007/978-94-009-2528-1_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sachs, Leo. "Hematopoietic Growth and Differentiation Factors and the Reversal of Malignancy." In Tumor Cell Differentiation. Humana Press, 1987. http://dx.doi.org/10.1007/978-1-4612-4594-0_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ruiz-Llorente, Lidia, María Jesús Ruiz-Rodríguez, Claudia Savini, et al. "Correlation Between Endoglin and Malignant Phenotype in Human Melanoma Cells: Analysis of hsa-mir-214 and hsa-mir-370 in Cells and Their Extracellular Vesicles." In Advances in Experimental Medicine and Biology. Springer Nature Switzerland, 2023. http://dx.doi.org/10.1007/978-3-031-26163-3_14.

Full text
Abstract:
AbstractEndoglin (CD105) is an auxiliary receptor of transforming growth factor (TGF)-β family members that is expressed in human melanomas. It is heterogeneously expressed by primary and metastatic melanoma cells, and endoglin targeting as a therapeutic strategy for melanoma tumors is currently been explored. However, its involvement in tumor development and malignancy is not fully understood. Here, we find that endoglin expression correlates with malignancy of primary melanomas and cultured melanoma cell lines. Next, we have analyzed the effect of ectopic endoglin expression on two miRNAs (h
APA, Harvard, Vancouver, ISO, and other styles
6

Stanbridge, Eric J. "Differentiation as a Mechanism for Control of Malignancy in Human Cell Hybrids." In Tumor Cell Differentiation. Humana Press, 1987. http://dx.doi.org/10.1007/978-1-4612-4594-0_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Luo, Weibo, and Yingfei Wang. "Hypoxia Mediates Tumor Malignancy and Therapy Resistance." In Advances in Experimental Medicine and Biology. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-12734-3_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Naor, David, Benjamin Y. Klein, Nora Tarcic, and Jonathan S. Duke-Cohan. "Antigenic Entities of the Tumor That Induce Suppressor Cells May Prevent the Potentiation of Coexpressed Immunogenic Entities." In Immunosuppression and Human Malignancy. Humana Press, 1989. http://dx.doi.org/10.1007/978-1-4612-4496-7_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hatanaka, Naoya, Mitsuru Futakuchi, and Takashi Suzuki. "Mathematical Modeling of Tumor Malignancy in Bone Microenvironment." In Springer Proceedings in Mathematics & Statistics. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-4866-3_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Caulfield, Michael P., Roberta L. McKee, John E. Fisher, et al. "Tumor-Secreted Protein Associated with Human Hypercalcemia of Malignancy." In ACS Symposium Series. American Chemical Society, 1991. http://dx.doi.org/10.1021/bk-1991-0444.ch016.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Malignancy tumor"

1

Pandey, Divya, Neha Pruthi, and Sudha Salhan. "Unusually high serum Ca 19-9 in a benign ovarian tumor." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685327.

Full text
Abstract:
Introduction: Ovarian tumors have a varied spectrum of presentation. Tumors which look malignant clinico-biochemically can ultimately turn out to be benign. Tumor markers help in diagnosing various malignancies. Carbohydrate antigen 19-9 is one such marker seen to be elevated in some ovarian tumors. Case: A 55 year old, lean and thin postmenopausal female presented to Gynae OPD with abdominal mass, anorexia and weight loss developing over last 6 months. During workup, she was found to have unusually high Ca 19-9 along with MRI findings suggestive of ovarian tumor. Staging laparotomy followed b
APA, Harvard, Vancouver, ISO, and other styles
2

Savita, Pannu, and Khullar Harsha. "Two interesting cases of granulosa cell tumor: A case report." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685326.

Full text
Abstract:
Introduction: Granulosa cell tumor (GCT) is an ovarian malignancy that arise from granulosa cells of the ovary. This tumour is a type of the sex cord-gonadal stromal tumour. GCT have good prognosis in comparison with other epithelial tumors. Methodology: Two cases of granulosa cell tumors were diagnosed in sir Ganga ram hospital, Rajendernagar, New Delhi in December 2015 and January 2016. The patient’s age, clinical manifestations, radiological and histopathological findings were evaluated. One was in perimenopausal age group and other case was in postmenopausal age group. The clinical manifes
APA, Harvard, Vancouver, ISO, and other styles
3

Savita, Pannu, and Khullar Harsha. "Two interesting cases of granulosa cell tumor: A case report." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685309.

Full text
Abstract:
Introduction: Granulosa cell tumor (GCT) is an ovarian malignancy that arise from granulosa cells of the ovary. This tumour is a type of the sex cord-gonadal stromal tumour. GCT have good prognosis in comparison with other epithelial tumors. Methodology: Two cases of granulosa cell tumors were diagnosed in sir Ganga ram hospital, Rajender Nagar, New Delhi in December 2015 and January 2016. The patient’s age, clinical manifestations, radiological and histopathological findings were evaluated. One was in perimenopausal age group and other case was in postmenopausal age group. The clinical manife
APA, Harvard, Vancouver, ISO, and other styles
4

Paula, Dênia Reis de, Benedito de Sousa Almeida Filho, Carla Priscila Kamiya Carvalho Pessoa, Heloisa Maria De Luca Vespoli, and Eduardo Carvalho Pessoa. "THE CORRELATION BETWEEN ULTRASSONOGRAFIC PREDICTORS, LOBAR ANATOMY AND TUMOR BIOLOGY." In Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1016.

Full text
Abstract:
Introduction: Since the 90s, breast ultrasound (US) features that predict malignancy or benignity are well established, but recently Stravos and Taboul et al. brought new concepts that set out to understand lobar anatomy and its relationship with breast lesions. Nowadays we seek to understand the relationship between breast anatomy and imaging to differentiate malignant from benign lesions and to predict their biological behavior. Objectives: To correlate breast lesions morphology and tumor biology with BIRADS® ultrasound predictors. Methods: This study was performed from 2012 to 2017. A total
APA, Harvard, Vancouver, ISO, and other styles
5

Camacho, Ana Thereza da Cunha Uchoa, Ana Paula Pontes Rodrigues, Maria Clara Sousa Peixoto, Rebeca de Sousa França, and Lívia Nazaré Soares Silva. "RECURRENT PHYLLODES TUMOR MALIGNANCY: A CASE REPORT." In XXIV Congresso Brasileiro de Mastologia. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s1070.

Full text
Abstract:
Fibroepithelial tumors of the breast are part of a heterogeneous group of biphasic neoplasms, which include common fibroadenomas (FA) and phyllodes tumors (PTs). The PT is a rare fibroepithelial tumor that is histologically divided into three grades: benign, malignant, or borderline. Although only about 10% of these tumors are malignant, even benign tumors are prone to local recurrence and can become very large in size. The standard management of PT is surgical excision with negative surgical margins, due to the propensity for local recurrence. Therefore, the report about this type of tumor wi
APA, Harvard, Vancouver, ISO, and other styles
6

Tanaka, Shotaro, Shinae Kizaka-Kondoh, and Hasahiro Hiraoka. "Imaging probe for tumor malignancy." In SPIE BiOS: Biomedical Optics, edited by Samuel Achilefu and Ramesh Raghavachari. SPIE, 2009. http://dx.doi.org/10.1117/12.808380.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chandra, Varkha, Sandhya Jain, Neerja Goel, Bindia Gupta, and Shalini Rajaram. "Multiple recurrence of granulosa cell tumor of the ovary: A case report and literature review." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685319.

Full text
Abstract:
Introduction: Granulosa cell tumors comprise approximately 5% of all ovarian malignancy and account for 70% of malignant sex cord stromal tumors. Granulosa cell tumors have been diagnosed from infancy, the peak incidence being perimenopausal age. The potential of malignancy of these tumors is low, recurrences are often late and found in 10-33% of cases. Case Report: A 32-year-old P1L1 presented with large abdominal mass for which she underwent staging laparotomy with debulking surgery. She was a known case of granulosa cell tumor in the past and had undergone three laparotomies, along with che
APA, Harvard, Vancouver, ISO, and other styles
8

Chandra, Varkha, Sandhya Jain, Neerja Goel, Bindia Gupta, and Shalini Rajaram. "Multiple recurrence of granulosa cell tumor of the ovary: A case report and literature review." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685296.

Full text
Abstract:
Introduction: Granulosa cell tumors comprise approximately 5% of all ovarian malignancy and account for 70% of malignant sex cord stromal tumors. Granulosa cell tumors have been diagnosed from infancy, the peak incidence being perimenopausal age. The potential of malignancy of these tumors is low, recurrences are often late and found in 10-33% of cases. Case Report: A 32-year-old P1L1 presented with large abdominal mass for which she underwent staging laparotomy with debulking surgery. She was a known case of granulosa cell tumor in the past and had undergone three laparotomies, along with che
APA, Harvard, Vancouver, ISO, and other styles
9

Queiroz, Andrei Alves de, Gustavo Machado Badan, Marilucia Batina Fernandes Moreira, and Amanda Neves Machado. "IMPACT OF COVID-19 ON BREAST CANCER TUMOR SIZE AT DIAGNOSIS." In Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1006.

Full text
Abstract:
Introduction: In 2020, COVID-19 affected the whole world, determining a pandemic situation, with recommendations for social isolation and lockdown. In the state of São Paulo, the shutdown of non-essential services was determined on March 22, 2020. Medical appointments and routine imaging exams were postponedand little is known about the impact on screening delay and the diagnosis of neoplasms. Considering that survival and cure of breast cancer are directly related to an early diagnosis, the size of these malignant tumors can be used in researching the delay in breast cancer diagnoses. Objecti
APA, Harvard, Vancouver, ISO, and other styles
10

Tang, Xin, Tony Cappa, Theresa B. Kuhlenschmidt, Mark S. Kuhlenschmidt, and Taher A. Saif. "Studying the Mechanical Sensitivity of Human Colon Cancer Cells Through a Novel Bio-MEMS Force Sensor." In ASME 2010 First Global Congress on NanoEngineering for Medicine and Biology. ASMEDC, 2010. http://dx.doi.org/10.1115/nemb2010-13237.

Full text
Abstract:
Cancer deaths are primarily caused by metastases, not by the parent tumor. During the metastasis, malignant cancer cells detach from the parent tumor, and spread through the patient’s circulatory system to invade new tissues and organs [1]. To study the role played by the mechanical microenvironment on the cancer cell growth and malignancy promotion, we cultured human colon carcinoma (HCT-8) cells in vitro on substrates with varied mechanical stiffness, from the physiologically relevant 1 kPa, 20 kPa to very stiff 3.5 GPa. A novel and versatile micro-electromechanical systems (Bio-MEMS) force
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Malignancy tumor"

1

Tran, Emily, Jasmine J. Park, Nandini N. Kulkarni, and Vinay S. Gundlapalli. Left Facial Primary Leiomyosarcoma Misdiagnosed as Atypical Fibroxanthoma and Immunochemical Markers Relevant to Diagnosis: A Case Report. Science Repository, 2024. http://dx.doi.org/10.31487/j.ajscr.2023.04.03.

Full text
Abstract:
Soft tissue sarcomas are relatively rare neoplasms of mesenchymal origin that generally make up less than 2% of all adult malignant neoplasms. Atypical fibroxanthoma is a benign soft tissue tumor often confused with malignant variants of similar tumors such as leiomyosarcoma due to similar staining markers and cell morphology. We report a case of a 70-year-old caucasian male who initially presented with a 2 cm exophytic left facial lesion that was misdiagnosed as atypical fibroxanthoma upon biopsy. The patient underwent a wide local excision of the growing 11 cm mass and immediate reconstructi
APA, Harvard, Vancouver, ISO, and other styles
2

Rogalska, Marta, Lukasz Antkowiak, Anna Kasperczuk, and Wojciech Scierski. Contrast-enhanced ultrasound in the differentiation between the most common benign parotid gland tumors: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.12.0042.

Full text
Abstract:
Review question / Objective: To determine the utility of CEUS in the preoperative differentiation between pleomorphic adenomas (PAs) and Warthin’s tumors (WTs) of the parotid gland. Condition being studied: Recently, contrast-enhanced ultrasound (CEUS) has become a promising tool in distinguishing benign from malignant parotid gland tumors. However, its usefulness in differentiating various benign parotid tumors has not been determined so far. The preoperative differentiation of the most common parotid gland tumors (PAs and WTs) remains crucial to select an appropriate management strategy. The
APA, Harvard, Vancouver, ISO, and other styles
3

Deng, Chun, Zhenyu Zhang, Zhi Guo, et al. Assessment of intraoperative use of indocyanine green fluorescence imaging on the number of lymph node dissection during minimally invasive gastrectomy: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.11.0062.

Full text
Abstract:
Review question / Objective: Whether is indocyanine green fluorescence imaging-guided lymphadenectomy feasible to improve the number of lymph node dissections during radical gastrectomy in patients with gastric cancer undergoing curative resection? Condition being studied: Gastric cancer was the sixth most common malignant tumor and the fourth leading cause of cancer-related death in the world. Radical lymphadenectomy was a standard procedure in radical gastrectomy for gastric cancer. The retrieval of more lymph nodes was beneficial for improving the accuracy of tumor staging and the long-term
APA, Harvard, Vancouver, ISO, and other styles
4

Gareau, Paul, and Brian K. Rutt. Prediction of Malignancy in Breast Tumors Using Diffusion Weighted Magnetic Resonance Imaging. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada390993.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sherman, Larry S. Role of CD44 in Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada411293.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sherman, Larry S. Role of CD44 in Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada420927.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zhu, Mucheng, Zhenhua Lu, Hao Guo, Xiaoting Gu, Defang Wei, and Zhengyi Zhang. Diagnostic Value of Combination of Biomarkers for Malignant Pleural Mesothelioma：Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.10.0043.

Full text
Abstract:
Review question / Objective: Tumor biomarkers have become increasingly attractive due to their non-invasive properties and relatively inexpensive nature for early diagnosis of Malignant pleural mesothelioma (MPM) .Many scholars have published studies on DNA and protein as biomarkers for early diagnosis of MPM, which might be a new breakthrough. A new meta-analysis is necessary to compare the accuracy of combination of three kinds of DNA and three kinds of proteins. Condition being studied: XAs the previous studies have a certain controversy about DNA as a biomarker of MPM, we conducted a syste
APA, Harvard, Vancouver, ISO, and other styles
8

Vogel, Kristine S. Cell Motility and Invasiveness of Neurofibromin-Deficient Neural Crest Cells and Malignant Triton Tumor Lines. Defense Technical Information Center, 2005. http://dx.doi.org/10.21236/ada439284.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Vogel, Kristine S. Cell Motility and Invasiveness of Neurotibromin-Deficient Neural Crest Cells and Malignant Triton Tumor Lines. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada411714.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Vogel, Kristine S. Cell Motility and Invasiveness of Neurofibromin-Deficient Neural Crest Cells and Malignant Triton Tumor Lines. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada422403.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Malignancy tumor' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography